EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the Bioequivalence of two Linagliptin/Metformin Hydrochloride 2.5/1000 mg Fixed-Dose Combination Tablets in Healthy Adults Under Fed Conditions: A Study from Bangladesh

Sabrina Akter Tushi, Md. Ashiqur Rahman, Uttom Kumar Bhowmik, Nayan Ghosh, Nithon Chandra Sahana, Md. Ashraful Islam

Journal of Pharmacy and Pharmacology Research · 2025

DOI: 10.26502/fjppr.0116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology Research, 2025. Verfasst von Sabrina Akter Tushi und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tushi, S. A., Rahman, M. A., Bhowmik, U. K., Ghosh, N., Sahana, N. C., & Islam, M. A. (2025). Evaluation of the Bioequivalence of two Linagliptin/Metformin Hydrochloride 2.5/1000 mg Fixed-Dose Combination Tablets in Healthy Adults Under Fed Conditions: A Study from Bangladesh. Journal of Pharmacy and Pharmacology Research. https://doi.org/10.26502/fjppr.0116

Vancouver

Tushi SA, Rahman MA, Bhowmik UK, Ghosh N, Sahana NC, Islam MA. Evaluation of the Bioequivalence of two Linagliptin/Metformin Hydrochloride 2.5/1000 mg Fixed-Dose Combination Tablets in Healthy Adults Under Fed Conditions: A Study from Bangladesh. Journal of Pharmacy and Pharmacology Research. 2025. doi:10.26502/fjppr.0116

BibTeX
@article{Tushi2025,
  author = {Tushi, Sabrina Akter and Rahman, Md. Ashiqur and Bhowmik, Uttom Kumar and Ghosh, Nayan and Sahana, Nithon Chandra and Islam, Md. Ashraful},
  title = {Evaluation of the Bioequivalence of two Linagliptin/Metformin Hydrochloride 2.5/1000 mg Fixed-Dose Combination Tablets in Healthy Adults Under Fed Conditions: A Study from Bangladesh},
  journal = {Journal of Pharmacy and Pharmacology Research},
  year = {2025},
  doi = {10.26502/fjppr.0116}
}
Kostenlos starten →